Markets
← Back to Stocks
DHR
DANAHER CORP
Health Care · Life Sciences Tools & Services
$190.44
-0.55%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
$9.9 billion Masimo acquisition powers Danaher diversification drives analyst confidence on growth
Danaher's $9.9 billion acquisition of pulse oximeter maker Masimo strengthens its position in healthcare and data monitoring, with analysts maintaining a Strong Buy rating and $264.05 price target. The stock trades at $188.00 in pre-market down 0.93% on profit-taking after strong Q4 earnings results. Robust growth in bioprocessing and diagnostics offsets near-term market uncertainty.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$134.4B
P/E (TTM)37.7
Forward P/E20.9
Beta0.96
Div Yield84.00%
Prev Close$191.50
RSI (14-Day)
28Oversold
0305070100
52-Week Range
$171.00$190.44$242.80
From High-21.6%
From Low+11.4%
Moving Averages
50d SMA
$215.77-11.7%
200d SMA
$209.93-9.3%
Price below 200d MA — bearish structure.
Returns
1W
+2.2%
1M
-8.7%
3M
-15.1%
6M
-1.0%
1Y
-9.9%
YTD
-17.3%
Volume
Today67K
20d Avg3.7M
Ratio0.02x